| (EUR) | Dec 2018 | Y/Y change |
|---|---|---|
| Revenue | 145.00K | -82.61% |
| Operating expense | — | — |
| Net income | -10.78M | -27.35% |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, ALNEV.PA returned -100.0% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -99.3% |
| 1 year | -100.0% |
| 5 years | -100.0% |
| 10 years | -100.0% |
| All-time high | €356,390,976.00 (Feb 2012) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what €1,000 in ALNEV.PA would be worth today ›No. Neovacs S.A. has not paid a dividend in the past 12 months.
Neovacs S.A. is part of the Healthcare sector.
Neovacs S.A. has a market cap of 30.00 EUR, based on the latest quote.
